Extended Data Fig. 4: Correlation between CM-DILI PRSgw and biomarkers for DILI in TAK-875 treated subjects.
From: Polygenic architecture informs potential vulnerability to drug-induced liver injury
Scatter plot and the linear regression line of clinical laboratory test value in basal state and CM-DILI PRSgw in 172 TAK-875 treated patients (cases and controls). *, p < 0.05; **, p < 0.01, ***, p < 0.001 in coefficients of risk score. ALTB, Basal ALT; ASTB, Basal AST; BILTB, Basal total bilirubin.
